Register an account to search through 14,000+ stocks! 

BNR – Burning Rock Biotech Ltd

✔ COMPLIANT

★★☆

Company Profile

Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The Company mainly conducts its businesses in the China market.

Business

PASS

Burning Rock Biotech Ltd has cleared the Business screen. Its business activity is compliant with the Shariah standard and its impure income is less than 5%. If you find this result mistaken or questionable, let us know in the comments.

Problematic Revenues N/A
Interest & Investment Income%
0.74%
Total 0.74%

Fundamentals

Market cap $1531635364
Assets
$408126897
ROA
-24.03
Div./Share
$-0.978879148

Financials

PASS

The financials pass two standards and fail in one.

Debt/A Cash/A (AR+C)/A
1.76%
84.97%
89.19%
< 33%
< 33%
< 50%
P
F
F
Debt/MC Cash/MC
0.47%
22.64%
< 30%
< 30%
P
P
Debt/24MC Cash/24MC AR/24MC
0.27%
84.97%
0.65%
< 33%
< 33%
< 33%
P
P
P

Note: A = Assets | AR = Accounts Receivables | MC = Market cap | 24MC = 24 month avg. Market cap

✘ FTSE ✔ AAOIFI ✔ DJIM

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Responses